logo-loader
TSX-V:DMA

DiaMedica

Receive alerts
Market:
TSX-V
Market Cap:
-
Price
CAD
Change
-
52 weeks high
-
52 weeks low
-

In brief

DiaMedica Inc. (DiaMedica) is a biopharmaceutical company that develops therapeutic products designed for Type 1 diabetes, Type 2 diabetes treatment and certain other medically-unmet diseases.